Arnold, LM, Goldenberg, DL, Stanford, SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007; 56:1336.

Arnold, LM, Hess, EV, Hudson, JI, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191.

Arnold, LM, Hudson, JI, Hess, EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50:944.

Arnold, LM, Lu, Y, Crofford, LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974.

Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119:5-15.

Bennett, RM, Kamin, M, Karim, R, Rosenthal, N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003; 114:537.

Busch, A, Schachter, CL, Peloso, PM, Bombardier, C. Exercise for treating fibromyalgia syndrome (Cochrane Review). Cochrane Database Syst Rev 2002; :CD003786.

Burckhardt CS, Clark SR, Benett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:475-479.

Carette, J, Bell, MJ, Reynolds, WJ, Haraoui, B, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32.

Cohen, H, Buskila, D, Neumann, L, Ebstein, RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002; 46:845.

Crofford, LJ, Rowbotham, MC, Mease, PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52:1264.

Dobkin PL, Sita A, Sewitch MJ. Predictors of adherence to treatment in women with fibromyalgia. Clin J Pain 2006 22:286-294.

Goldenberg DL. Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 1999;159:777-85.

Goldenberg, DL, Burckhardt, C, Crofford, L. Management of fibromyalgia syndrome. JAMA 2004; 292:2388.

Goldenberg, DL, Mayskiy, M, Mossey, CJ, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852.

Fitzcharles, MA, Boulos, P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 2003; 42:263.

Hakkinen, A, Hakkinen, K, Hannonen, P, Alen, M. Force production capacity and acute neuromuscular responses to fatiguing loading in women with fibromyalgia are not different from those of healthy women. J Rheumatol 2000; 27:1277.

Henriksson KG. Fibromyalgia-from syndrome to disease: overview of pathogenetic mechanisms. J Rehabil Med. 2003(41 suppl):89-94.

Hooten, WM, Townsend, CO, Sletten, CD, et al. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007; 8:8.

Kuchinad, A, Schweinhardt, P, Seminowicz, DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?. J Neurosci 2007; 27:4004.

Kwiatek, R, Barnden, L, Tedman, R, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000; 43:2823.

Nielson WR, Jensen MP. Relationship between changes in coping and treatment outcome in patients with fibromyalgia syndrome. Pain 2004; 109:233.

Patkar, AA, Masand, PS, Krulewicz, S, et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 2007; 120:448.

Russell, IJ, Orr, MD, Littman, B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37:1593.

Salemi, S, Aeschlimann, A, Wollina, U, et al. Upregulation of delta-opiod receptors and kappa-opiod receptors in the skin of fibromyalgia patients. Arthritis Rheum 2007; 56:2464.

Simms, RW, Goldenberg, DL. Symptoms mimicking neurologic disorders in fibromyalgia syndrome. J Rheumatol 1988; 15:1271

Swetich MJ, Dobkin PL, Beratsky S, et al. Medication non-adherence in women with fibromylagia. Rheumatology 2004 43:648-654.

Tofferi, JK, Jackson, JL, O'Malley, PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 2004; 51:9.

Triadafilopoulos G, Simms RW, Goldenberg DL. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci. 1991;36:59-64.

Tunks, E, McCain, GA, Hart, LE, Teasell, RW, et al. The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 1995; 22:944.

Weir, PT, Harlan, GA, Nkoy, FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006; 12:124.

White, KP, Nielson, WR, Harth, M, et al. Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 2002; 47:260.

White, KP, Speechley, M, Harth, M, et al. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. Arthritis Rheum 1999; 42:76.

White, KP, Speechley, M, Harth, M, Ostbye, T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 2000; 29:44.

Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40:1560-1570.

Yunus, MB. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36:339.